Compare Republic Services Inc. Common Stock (RSG) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Republic Services Inc. Common Stock vs Smith & Nephew plc — how do they compare? Republic Services Inc. Common Stock trades at $227.89 (market cap $68.73B), while Smith & Nephew plc trades at $28.38 (market cap $11.65B). The key difference: Republic Services Inc. Common Stock is far larger — about 5.9× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.85%). Which is the better fit depends on your goals.
| RSG | SNN | |
|---|---|---|
Market Cap | $68.73B | $11.65B |
Volume | 1,226,777 | 860,347 |
Sector | Industrials | Health |
52-Week High | $232.27 | $37.17 |
52-Week Low | $197.73 | $26.42 |
Enterprise Value | $82.91B | $14.68B |
Dividend Yield | 1.19% | 2.85% |
Typical Hold Time | — | 121 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SNN trades at $27.86, near a 52-week low, with a mixed technical signal. Revenue has grown from $5.2B in 2022 to $6.16B in 2025, with net income margin improving to 10.08%. Recent product launches like the EVOS PELVIC System highlight innovation, but the stock faces headwinds from analyst downgrades and CFO departure news.
The outlook is cautious; while fundamentals show steady growth and a reasonable P/E of 18.95, weak sentiment and technical pressure near lows suggest limited near-term upside. Risks include execution challenges and competitive threats, but long-term investors may find value if operational improvements materialize.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Republic Services Inc. Common Stock
Republic Services Inc. is a waste management company that provides non-hazardous solid waste collection, transfer, disposal, and recycling services across North America.
Read more on RSG →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
